Dynamic transcriptional immune landscape in response to NK-cell therapy combined with gemcitabine plus S-1 in advanced pancreatic cancer: a phase 1b/2 trialQin Tan, Jie Ma, Caixia Liu et al.|Signal Transduction and Targeted Therapy|2025Cited by 0